Olema Pharmaceuticals, Inc. (OLMA) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $54.87M | +30.6% |
| 2024 | $42.02M | +82.3% |
| 2023 | $23.05M | +27.4% |
| 2022 | $18.10M | +59.1% |
| 2021 | $11.38M | +148.1% |
| 2020 | $4.58M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $54.87M | +30.6% |
| 2024 | $42.02M | +82.3% |
| 2023 | $23.05M | +27.4% |
| 2022 | $18.10M | +59.1% |
| 2021 | $11.38M | +148.1% |
| 2020 | $4.58M | — |